Blog / Archives
Snap-Back Rally in Biotech Up 4+% Friday
Life Science Stocks Surge Ahead From February Lows NASDAQ Up 1.67%, IBB Up 4%, FBIOX up 4.72%, XBI up 5.64%, XLV up 1.7% The soaring biotech sector would not let a losing week go by and took off...
Biotech Bull Market Up 6%+YTD: Key Trends to Watch Update #2
Biotech Bull Market Intact But Technicals Rule On January 27 we reiterated our model for life science stocks for 2014. We will review each component of our model and where the sector stands after...
Rayno Dx and Tools Stocks Up in January: CPHD, ILMN
Molecular Diagnostics and Sequencing Technologies Are Big Winners in January 2014 But Recent Two Day Sell-Off Has Done Damage To Many Stocks Diagnostic stocks were a sea of red today after a huge...
Rayno Biopharmaceutical Stocks Soar In January: ALXN, BIIB, PCYC Beat Indices
But Momentum Is Easing As Investors Cash Out-IBB Is 5.5% Off Jan 22 Highs Caution Rules With Selling Pressure-Raise Cash to 15% January 2014 was up 12% which may be the best month ever in...
Rayno Life Science Stocks: CPHD, ILMN, SQNM
A Few Winners on A Weak Day-IBB ($247.80) Down 1.22% Slightly Off Highs of $254. Two of Our Best DX Picks Have Been Cepheid and Illumina Cepheid (CPHD $53) up 12% on 20% Q4 Revenue Gains . Full year...
Rayno Life Science Stocks: ALXN, BIIB, GILD, REGN, RHHBY Update 1
Update 12:40p NASDAQ Up 2% Cardiovascular Sciences (CSII $33.90) Up 15 %-Beats on Revenues and EPS. Q2 Revenues up 28% to $32.3M. Net Loss was $8.7M compared to $5.8M in 2013 fiscal Q2. Thermo...
Sidebar To Cult Momentum Stocks: AMZN, NFLX, TSLA, TWTR
Update 2/3/14 NetLaZon=$927 vs $979 down 5.3% since 1/29/14 =NFLX+TSLA+AMZN Momentum Still Rules With not much to say about biotech today except it appears unfazed by macro news (see BIIB $316 up...
Biotech Stocks Recover From 5 Day 5% Sell-Off
Plenty Of FirePower Left In Biotech-IBB Up 2.2% At $244 Biotechnology stocks have been quite volatile and not immune to downdrafts but today they made an impressive recovery. Nonetheless I would be...
Speculative Fever Broken In Biotech But Sector Still Up 5% YTD
Follow Technical Levels -Avoid High Flyers Five Trends To Watch In Biotech-Preliminary Model Large Cap Biopharmaceuticals: metrics already reviewed-awaiting 2013 financial reporting. Key Technicals...
Biotech Sell-Off Down 1%+: Was Goldman Call Right? Update 1/24 2:20p
Update 1/24 With 2 hrs Trading to go.....Technical levels holding with sector up 7-8% YTD. NASDAQ still falling down 1.9% at 4139, QQQ down 1.5% Given the huge 11% move through the J.P.Morgan...